SBC — SBC Medical group Cashflow Statement
0.000.00%
Last trade - 00:00- $459.00m
- $335.47m
- $205.42m
- 94
- 72
- 35
- 76
Annual cashflow statement for SBC Medical group, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 5.55 | 38.6 | 46.7 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 2.96 | 3.4 | 31.4 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -10.6 | -7.65 | -46.9 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -0.047 | 50.7 | 20.6 |
| Capital Expenditures | -24.9 | -11.2 | -3.41 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -7.71 | 13 | -6.69 |
| Acquisition of Business | |||
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -32.7 | 1.79 | -10.1 |
| Financing Cash Flow Items | -2.89 | 2.56 | 11 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -7.98 | 6.14 | 23 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -52.8 | 51.3 | 22 |